{"filing":{"accession_number":"0001493152-26-036742","cik":"0001971532","ticker":"TELO","company_name":"Telomir Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226036742/form8-k.htm"},"events":[{"id":26391,"run_id":23982,"accession_number":"0001493152-26-036742","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses publication of peer-reviewed preclinical research demonstrating Telomir-Zn's mechanism of action and anti-tumor activity in TNBC and prostate cancer models. This is a material operational/scientific milestone for a clinical-stage biotech company, supporting advancement toward Phase 1/2 trials. While not a traditional earnings release or regulatory approval, the publication represents meaningful progress in the company's development pipeline and would affect a reasonable investor's assessment of the lead program's viability.","company_name":"Telomir Pharmaceuticals, Inc.","ticker":"TELO","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":27491,"accession_number":"0001493152-26-036742","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses publication of peer-reviewed preclinical research demonstrating Telomir-Zn's mechanism of action and anti-tumor activity in TNBC and prostate cancer models. This is a material operational/scientific milestone for a clinical-stage biotech company, supporting advancement toward Phase 1/2 trials. While not a traditional earnings release or regulatory approval, the publication represents meaningful progress in the company's development pipeline and would affect a reasonable investor's assessment of the lead program's viability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T12:02:15.309110+00:00","company_name":"Telomir Pharmaceuticals, Inc.","ticker":"TELO","filing_date":"2026-08-10"}]}